Nasal Vaccines Market Expanding At A Cagr In Terms Of Value Over The Forecast Period 2023–2030 AstraZeneca GlaxoSmith
Nasal vaccines offer several advantages compared to traditional injectable vaccines. They are non-invasive, painless, and do not require needles or syringes, which can be beneficial for individuals with needle phobia or for vaccine administration in large-scale vaccination programs. Nasal vaccines also stimulate both systemic and mucosal immune responses, as the nose and respiratory tract are important entry points for many pathogens.
Comments
Log in to comment or register here .